Kezar Life Sciences, Inc. — Director's Dealing 2019

Aug 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2019-08-13

Reporting Person: Kirk Christopher J. (Director, President and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-13	Common Stock	P	5000	$4.608	Acquired	302934	Direct

Footnotes

F1: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.5935 to $4.621 on August 13, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of issuer, full information regarding the number of shares purchased at each separate price.